Scientists of the KIT and the University of Kiev have produced an antibiotic, whose biological activity can be controlled with light.
Thanks to the robust diarylethene photoswitch, the antimicrobial effect of the peptide mimetic can be applied in a spatially and temporally specific manner. This might open up new options for the treatment of local infections, as side effects are reduced. The researchers present their photoactivable antibiotic with the new photomodule in a “Very Important Paper” of the journal “Angewandte Chemie”.
Photoswitchable molecules modify their structure and properties when exposed to light of an adequate wavelength. Among the photoswitches known are diarylethenes. By reversible photoisomerization, i.e. a reversible light-induced internal relocation of the molecule, the open form is turned into a closed form. Such photoswitch-able molecules are applied in molecular electronics and many other areas. Particularly interesting opportunities result from the insertion of photoswitches into biomolecules to control their activity by light. Interest focuses on so-called peptide mimetics, compounds whose major structural elements emulate a peptide, i.e. a small protein.
For the first time now, a group of researchers headed by Professor Anne S. Ulrich, Director of the Institute for Biological Interfaces 2 (IBG2) and holder of the Chair for Biochemistry at the Institute of Organic Chemistry (IOC) of KIT, has produced a photoswitchable peptide mimetic based on a diarylethene scaffold that can be photoisomerized reversibly. The scientists modified this building block into an amino acid analog and incorporated it directly into the backbone of the annular peptide antibiotic Gramicidin S. Biological activity of the resulting peptide mimetic can be controlled spatially and temporally with the help of UV and visible light. To demonstrate this, the scientists treated a bacterial film with the inactivated antibiotic and exposed it to light via a mask. As a result, the photoswitchable diarylethene was converted from a closed into an open form. Due to the structural modification induced, the entire substance molecule had a much higher antimicrobial effect. “In the future, such photoactivable antibiotics might be used as smart therapeutic agents against local bacterial infections,” Professor Anne S. Ulrich explains. “Usual side effects can also be minimized by switching.” Based on this strategy, new peptide-based agents against cancer might be feasible, as the newly developed photoactivable building block can also be applied in other peptide sequences.
The Latest on: Antibiotic
via Google News
The Latest on: Antibiotic
- Antibiotic intercepts building blocks of the bacterial envelopeon March 24, 2020 at 11:23 am
One of the last arrows in the quiver in the fight against dangerous bacteria is the reserve antibiotic daptomycin. It is used primarily when conventional drugs fail due to resistant bacteria. Although ...
- Cannabidiol helps fight antibiotic-resistant bacteriaon March 24, 2020 at 10:35 am
With fewer antibiotics available to treat resistant bacterial infections, the possibility of entering a pre-antibiotic era is looming ahead. Alternative strategies are being explored and helper ...
- Antibiotic resistance: the hidden threat lurking behind Covid-19on March 24, 2020 at 1:15 am
It is the hidden threat from antibiotic resistance — bacteria that are not killed by standard antibiotics. Unfortunately, the pipeline of drugs to manage these deadly infections is nearly dry.
- US to start trials of malaria drug and antibiotic to treat coronaviruson March 23, 2020 at 9:54 am
CNBC's Meg Tirrell reports on the latest trials for a combination of two existing drugs to treat coronavirus infections in patients.
- Global Antibiotic Resistance Market 2019 Size (value & volume) by Company, Key Regions/Countries, Products and Application 2025on March 23, 2020 at 6:52 am
Global Antibiotic Resistance Market, a new addition to the catalog of Fior Markets, provides an overview of the current state of the market and its evolution. The report contains a forecast of 2019 ...
- French study finds anti-malarial and antibiotic combo could reduce COVID-19 durationon March 19, 2020 at 5:14 pm
could be especially effective in treating the COVID-19 coronavirus and reducing the duration of the virus in patients. The researchers performed a study on 30 confirmed COVID-19 patients, treating ...
- Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonuson March 18, 2020 at 7:21 pm
The scarcity of novel antibiotic compounds in a time of increasing resistance rates has begun to ring alarm bells at the highest echelons of government. Large new financial incentives to accelerate ...
- Environmental remodeling of human gut microbiota and antibiotic resistome in livestock farmson March 18, 2020 at 3:07 am
Environments where antibiotics are used indiscriminately exhibit microbial communities that can represent hot-spots of resistance gene enrichment, which in turn could spread to humans. Here, the ...
- Dr. Jekyll and Mr. Hyde: Enzyme targeted by TB antibiotic later stops the drug destroying iton March 17, 2020 at 8:23 am
Crick and Imperial researchers have found that a key antibiotic widely used to treat drug-resistant tuberculosis does not work as expected—a finding which could be used to develop new drugs. The study ...
- MIT’s deep learning found an antibiotic for a germ nothing else could killon March 13, 2020 at 1:14 pm
It's a rule-breaker on many levels: Finding a novel use for an existing compound; using neural nets in place of familiar chemical definitions; and finding an antibiotic that doesn't behave like the ...
via Bing News